List of Tables
Table 1. Global Respiratory Biologics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Respiratory Biologics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Respiratory Biologics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Respiratory Biologics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Respiratory Biologics Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Respiratory Biologics Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Respiratory Biologics Sales by Region (2020-2025) & (K Units)
Table 8. Global Respiratory Biologics Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Respiratory Biologics Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Respiratory Biologics Sales Share by Manufacturers (2020-2025)
Table 12. Global Respiratory Biologics Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Respiratory Biologics Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Respiratory Biologics by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Biologics as of 2024)
Table 16. Global Respiratory Biologics Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Respiratory Biologics Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Respiratory Biologics Manufacturing Base and Headquarters
Table 19. Global Respiratory Biologics Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Respiratory Biologics Sales by Type (2020-2025) & (K Units)
Table 23. Global Respiratory Biologics Sales by Type (2026-2031) & (K Units)
Table 24. Global Respiratory Biologics Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Respiratory Biologics Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Respiratory Biologics ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Respiratory Biologics Sales by Application (2020-2025) & (K Units)
Table 29. Global Respiratory Biologics Sales by Application (2026-2031) & (K Units)
Table 30. Respiratory Biologics High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Respiratory Biologics Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Respiratory Biologics Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Respiratory Biologics ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Respiratory Biologics Growth Accelerators and Market Barriers
Table 37. North America Respiratory Biologics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Respiratory Biologics Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Respiratory Biologics Growth Accelerators and Market Barriers
Table 40. Europe Respiratory Biologics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Respiratory Biologics Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Respiratory Biologics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Respiratory Biologics Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Respiratory Biologics Growth Accelerators and Market Barriers
Table 45. Southeast Asia Respiratory Biologics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Respiratory Biologics Investment Opportunities and Key Challenges
Table 47. Central and South America Respiratory Biologics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Respiratory Biologics Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Respiratory Biologics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. GSK Corporation Information
Table 51. GSK Description and Major Businesses
Table 52. GSK Product Models, Descriptions and Specifications
Table 53. GSK Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. GSK Sales Value Proportion by Product in 2024
Table 55. GSK Sales Value Proportion by Application in 2024
Table 56. GSK Sales Value Proportion by Geographic Area in 2024
Table 57. GSK Respiratory Biologics SWOT Analysis
Table 58. GSK Recent Developments
Table 59. AstraZeneca Corporation Information
Table 60. AstraZeneca Description and Major Businesses
Table 61. AstraZeneca Product Models, Descriptions and Specifications
Table 62. AstraZeneca Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. AstraZeneca Sales Value Proportion by Product in 2024
Table 64. AstraZeneca Sales Value Proportion by Application in 2024
Table 65. AstraZeneca Sales Value Proportion by Geographic Area in 2024
Table 66. AstraZeneca Respiratory Biologics SWOT Analysis
Table 67. AstraZeneca Recent Developments
Table 68. Sanofi Corporation Information
Table 69. Sanofi Description and Major Businesses
Table 70. Sanofi Product Models, Descriptions and Specifications
Table 71. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Sanofi Sales Value Proportion by Product in 2024
Table 73. Sanofi Sales Value Proportion by Application in 2024
Table 74. Sanofi Sales Value Proportion by Geographic Area in 2024
Table 75. Sanofi Respiratory Biologics SWOT Analysis
Table 76. Sanofi Recent Developments
Table 77. Genentech USA Corporation Information
Table 78. Genentech USA Description and Major Businesses
Table 79. Genentech USA Product Models, Descriptions and Specifications
Table 80. Genentech USA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Genentech USA Sales Value Proportion by Product in 2024
Table 82. Genentech USA Sales Value Proportion by Application in 2024
Table 83. Genentech USA Sales Value Proportion by Geographic Area in 2024
Table 84. Genentech USA Respiratory Biologics SWOT Analysis
Table 85. Genentech USA Recent Developments
Table 86. Teva Respiratory Corporation Information
Table 87. Teva Respiratory Description and Major Businesses
Table 88. Teva Respiratory Product Models, Descriptions and Specifications
Table 89. Teva Respiratory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Teva Respiratory Sales Value Proportion by Product in 2024
Table 91. Teva Respiratory Sales Value Proportion by Application in 2024
Table 92. Teva Respiratory Sales Value Proportion by Geographic Area in 2024
Table 93. Teva Respiratory Respiratory Biologics SWOT Analysis
Table 94. Teva Respiratory Recent Developments
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Major Businesses
Table 97. Novartis Product Models, Descriptions and Specifications
Table 98. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Novartis Recent Developments
Table 100. Roche Corporation Information
Table 101. Roche Description and Major Businesses
Table 102. Roche Product Models, Descriptions and Specifications
Table 103. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Roche Recent Developments
Table 105. Boehringer Ingelheim Corporation Information
Table 106. Boehringer Ingelheim Description and Major Businesses
Table 107. Boehringer Ingelheim Product Models, Descriptions and Specifications
Table 108. Boehringer Ingelheim Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Boehringer Ingelheim Recent Developments
Table 110. Regeneron Pharmaceuticals Corporation Information
Table 111. Regeneron Pharmaceuticals Description and Major Businesses
Table 112. Regeneron Pharmaceuticals Product Models, Descriptions and Specifications
Table 113. Regeneron Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Regeneron Pharmaceuticals Recent Developments
Table 115. Merck Corporation Information
Table 116. Merck Description and Major Businesses
Table 117. Merck Product Models, Descriptions and Specifications
Table 118. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Merck Recent Developments
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Major Businesses
Table 122. Johnson & Johnson Product Models, Descriptions and Specifications
Table 123. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Johnson & Johnson Recent Developments
Table 125. Amgen Corporation Information
Table 126. Amgen Description and Major Businesses
Table 127. Amgen Product Models, Descriptions and Specifications
Table 128. Amgen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Amgen Recent Developments
Table 130. Biogen Corporation Information
Table 131. Biogen Description and Major Businesses
Table 132. Biogen Product Models, Descriptions and Specifications
Table 133. Biogen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Biogen Recent Developments
Table 135. Vertex Pharmaceuticals Corporation Information
Table 136. Vertex Pharmaceuticals Description and Major Businesses
Table 137. Vertex Pharmaceuticals Product Models, Descriptions and Specifications
Table 138. Vertex Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Vertex Pharmaceuticals Recent Developments
Table 140. AbbVie Corporation Information
Table 141. AbbVie Description and Major Businesses
Table 142. AbbVie Product Models, Descriptions and Specifications
Table 143. AbbVie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. AbbVie Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Biologics Product Picture
Figure 2. Global Respiratory Biologics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Intravenous Product Picture
Figure 4. Subcuteneous Product Picture
Figure 5. Global Respiratory Biologics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Asthma
Figure 7. Chronic Rhinosinasitis
Figure 8. Hypereosinophilic Syndrome
Figure 9. Other
Figure 10. Respiratory Biologics Report Years Considered
Figure 11. Global Respiratory Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 13. Global Respiratory Biologics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Respiratory Biologics Revenue Market Share by Region (2020-2031)
Figure 15. Global Respiratory Biologics Sales (2020-2031) & (K Units)
Figure 16. Global Respiratory Biologics Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Respiratory Biologics Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Respiratory Biologics Sales Volume Market Share in 2024
Figure 19. Global Respiratory Biologics Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Intravenous Revenue Market Share by Manufacturer in 2024
Figure 22. Subcuteneous Revenue Market Share by Manufacturer in 2024
Figure 23. Global Respiratory Biologics Sales Market Share by Type (2020-2031)
Figure 24. Global Respiratory Biologics Revenue Market Share by Type (2020-2031)
Figure 25. Global Respiratory Biologics Sales Market Share by Application (2020-2031)
Figure 26. Global Respiratory Biologics Revenue Market Share by Application (2020-2031)
Figure 27. North America Respiratory Biologics Sales YoY (2020-2031) & (K Units)
Figure 28. North America Respiratory Biologics Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Respiratory Biologics Sales Revenue (US$ Million) in 2024
Figure 30. North America Respiratory Biologics Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Respiratory Biologics Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Respiratory Biologics Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Respiratory Biologics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Respiratory Biologics Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Respiratory Biologics Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Respiratory Biologics Sales Revenue (US$ Million) in 2024
Figure 40. Europe Respiratory Biologics Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Respiratory Biologics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Respiratory Biologics Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Respiratory Biologics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 45. France Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Respiratory Biologics Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Respiratory Biologics Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Respiratory Biologics Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Respiratory Biologics Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Respiratory Biologics Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Respiratory Biologics Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Respiratory Biologics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 60. India Respiratory Biologics Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Respiratory Biologics Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Respiratory Biologics Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Respiratory Biologics Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Respiratory Biologics Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Respiratory Biologics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Respiratory Biologics Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Respiratory Biologics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Respiratory Biologics Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Respiratory Biologics Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Respiratory Biologics Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Respiratory Biologics Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Respiratory Biologics Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Respiratory Biologics Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Respiratory Biologics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Respiratory Biologics Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Respiratory Biologics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Respiratory Biologics Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Respiratory Biologics Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Respiratory Biologics Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Respiratory Biologics Revenue (2020-2025) & (US$ Million)
Figure 81. Respiratory Biologics Industry Chain Mapping
Figure 82. Regional Respiratory Biologics Manufacturing Base Distribution (%)
Figure 83. Global Respiratory Biologics Production Market Share by Region (2020-2031)
Figure 84. Respiratory Biologics Production Process
Figure 85. Regional Respiratory Biologics Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
